Therefore, it appears that the downregulation of S100A12 likely reduces apoptosis but does not inhibit the inflammation induced by hypoxia in individuals with AMS after ascension to high altitude. The gene discussed is S100A12; the disease is ablepharon macrostomia syndrome.